Anzeige
Mehr »
Login
Samstag, 29.03.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Kritischer Rohstoff, strategische Wende: Warum diese Aktie jetzt auf das Radar kluger Investoren gehört
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40CGS | ISIN: US4618741098 | Ticker-Symbol:
NASDAQ
27.03.25
17:33 Uhr
10,650 US-Dollar
+0,520
+5,13 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
EXOZYMES INC Chart 1 Jahr
5-Tage-Chart
EXOZYMES INC 5-Tage-Chart

Aktuelle News zur EXOZYMES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoNew to The Street's FOX Business Show #638 Spotlights Visionary CEOs and Breakthrough Innovations Across Health, AI, and Insurance Featuring BioVie CEO Cuong Do, Roadzen CEO Rohan Malhotra, Lou Basenese's The Big Skinny on eXoZymes, and Banzai CEO Joe Dav272Sponsored by The Sustainable Green Team and Featuring an Exclusive Interview with Former Shark Kevin Harringtonhttps://www.youtube.com/watch?v=EfMWKXgIqrINEW YORK CITY, NY / ACCESS Newswire / March...
► Artikel lesen
04.03.New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen , BioVie , AtlasClear , eXoZymes , and EvolveHealthandLifestyle.com With Craig Bruce368Also Featuring The Sustainable Green Team ($SGTM) with Shark Tank's Kevin Harrington Showcasing Their WaterLess Garden Product NEW YORK CITY, NY / ACCESS Newswire / March 3, 2025 / New to The Street...
► Artikel lesen
21.02.eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.134Monrovia, CA, Feb. 21, 2025 (GLOBE NEWSWIRE) -- eXoZymes Inc. (NASDAQ: EXOZ, formerly Invizyne Technologies) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential...
► Artikel lesen
21.02.EXOZYMES INC. - 8-K, Current Report-
19.02.eXoZymes Inc.: eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering1
10.02.Invizyne Technologies, Inc.: Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol169Monrovia, CA, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc., (NASDAQ: IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially...
► Artikel lesen
21.01.Invizyne Technologies CEO Michael Heltzen kauft Aktien im Wert von 20.345 US-Dollar2
19.11.24Invizyne Technologies selected for $2M project to advance sustainable aviation fuel capabilities1
EXOZYMES Aktie jetzt für 0€ handeln
19.11.24Invizyne Technologies, Inc.: Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities1
18.11.24Invizyne Technologies Inc - 8-K, Current Report-
14.11.24Invizyne Technologies, Inc.: Invizyne Technologies Announces Closing of Initial Public Offering201Monrovia, CA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and...
► Artikel lesen
13.11.24Invizyne Technologies, Inc.: Invizyne's Nasdaq IPO Marks New Era of Biomanufacturing180Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc., (NASDAQ:IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially...
► Artikel lesen
13.11.24Invizyne Technologies stock climbs 13% following $15M IPO6
13.11.24Invizyne Technologies Opens At $11.10, IPO Priced At $85
13.11.24Invizyne Technologies, Inc.: Invizyne Technologies Begins Trading on NASDAQ161Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and...
► Artikel lesen
12.11.24Invizyne Technologies Inc - 10-Q, Quarterly Report-
12.11.24Invizyne Technologies, Inc.: Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024133Monrovia, CA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and...
► Artikel lesen
12.11.24Biomanufacturing company Invizyne Technologies prices IPO at $85
12.11.24Invizyne Technologies prices $15M U.S. IPO7
21.10.24Invizyne Technologies Inc - S-1/A, General form for registration of securities1
Seite:  Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1